COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

ICCVAM Logo

ICCVAM Biennial Report 2018-2019

ICCVAM Biennial Report 2018-2019
Menu
https://ntp.niehs.nih.gov/go/891770

Cell-based Assays to Identify Chemical Targets

CCDC CBC has been assessing and validating a number of cell-based in vitro platforms, which are currently being optimized as predictive toxicological tools. As a result of these efforts, the center has a fully functional, high-throughput G protein-coupled receptor screening assay, as well as single receptor tests using engineered cell lines to assay ion channel effects. These cell-based platforms should allow rapid assessment of the effects of different chemical threats.

Thus far, the center has used the PRESTO-TANGO assay system to test the activity of alpha adrenergic receptor agonists against an entire library of G protein-coupled receptors. Data currently collected align with results obtained using in vivo systems. Current and future efforts aim to test G protein-coupled receptor agonism and antagonism of a number of different compounds of interest.

"Gut-endothelial Barrier Models Incorporating ..." - previous article
next article - "Phenotypic Screening Platforms for ..."
Tags: